Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Headlines

PPD files for IPO 8 years after going private in $3.9B deal

PPD files confidential paperwork for a planned IPO, eight years after being taken private by two private equity groups.

Sosei Heptares pulls dementia trial to minimize CRO expenditure

Sosei Heptares withdraws Phase II dementia with Lewy bodies trial to reduce spending on contract research while clinical activity is suspended.

'E-label' packaging to improve patient experience

Sharp’s electronic label for drug packaging can be updated again and again, saving time and costs whilst also improving patient engagement during clinical trials.

Dupixent drives up Regeneron spending on contract manufacturing

Regeneron Pharmaceuticals increases spending on collaboration and contract manufacturing by 39% on rising Dupixent sales.

Intercept activates contract sales force to support NASH drug launch

Intercept Pharmaceuticals prepares to introduce NASH drug onto the market by hiring a contract sales team.

Promotional Features

Content provided by Marken

How personalized medicines are disrupting the supply chain

Sponsors for a Phase 2 clinical trial needed an expensive, time-sensitive therapy transported to investigator sites at -80º C. Further, when reaching out to cryogenic shipper rental companies, the sponsor found they often transport regionally and do not...

Content provided by Dätwyler Sealing Solutions International

Datwyler's Starter Pack - A Single Source Solution for Drug Discovery Through Drug Delivery

Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global healthcare industry. The Swiss-based company offers state-of-the-art solutions for parenteral packaging and medical devices, built on more than 100 years of experience....